s portfolio with the launch of Restorative Skin Complex featuring Next Generation TriHex Technology (TriHex+TM). This formula includes two groundbreaking additions, proven to help visibly restore facial radiance and plumping by supporting the skin’s own regenerative abilities. In International markets, Galderma continued to roll-out key innovation, such as Cetaphil’s Bright Healthy Radiance or Gentle Exfoliating lines.

Therapeutic Dermatology

Therapeutic Dermatology net sales were 1,185 million USD, up 50.2% year-on-year at constant currency. Net sales growth was very strong, driven by an outstanding launch trajectory of Nemluvio in prurigo nodularis and atopic dermatitis. This more than offset the anticipated decline in the mature Therapeutic Dermatology portfolio in the U.S., along with modest growth from the mature portfolio in International markets.

For the year, Nemluvio contributed 452 million USD in net sales. The vast majority of Nemluv
=*=*=*=*=*=
当前为第13/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页